$INDI

McClymont Donald sold $209K of INDI

McClymont Donald (Chief Executive Officer) sold 50,000 shares of indie Semiconductor, Inc. (INDI) at $4.19 ($0.21M total) on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · McClymont Donald
Published Jun 18, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 12:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$INDI
Neutral
high confidence
Mentioned
$INDI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INDINeutralLow
01

Why it matters

The newest disclosed fact is the CEO’s open-market sale of 50,000 shares at a specified price, executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment/positioning, but 10b5-1 structure generally limits interpretive value.

03

What to watch

The filing does not disclose reasons for sale or any concurrent operational/financial updates; without follow-on news, trading impact should be limited.

Relevance 3/10Novelty 6/10Timing: SEC Form 4 filed 2026-06-17 for a 2026-06-15 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Indie Semiconductor, Inc. (INDI).

Company-level read

Ticker impact

$INDINeutralHigh confidence
Context

Indie Semiconductor CEO McClymont Donald sold 50,000 shares on 2026-06-15 at $4.1851/share under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of sustained price impact; any reaction is likely short-lived unless accompanied by other news.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst disclosed.

None indicated.

None indicated.

Counterpoint

A 10b5-1 sale can still coincide with personal liquidity needs rather than bearish fundamentals; the market may overreact to the headline sale size.

Key entities

  • indie Semiconductor, Inc.

    Subject of the Form 4 insider transaction; CEO sold shares under a 10b5-1 plan.

  • McClymont Donald

    CEO/Officer/Director who executed the sale.

Related articles

$INDIMedAI 8/10

Indie Semi Jumps on Revenue Increase

Indie Semiconductor (Nasdaq: INDI) shares rose 16% to $4.00 in after-hours after reporting 24% higher Q2 revenue versus the same period in 2025. For the current quarter, it expects revenue of $67 million to $73 million, implying about 30% YoY growth at the midpoint.

$INDIHigh

indie Semiconductor, Inc. (INDI): Results of Operations and Financial Condition

indie Semiconductor, Inc. (INDI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 indi-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 indie Reports Second Quarter 2026 Results • Delivers Revenue of $64M, up 24% Y-o-Y and exceeds midpoint of the guidance range • Guides for accelerating growth of 30% Y-o-Y in Q3 2026 • Substantially narrows GAAP and Non-GAAP

$HIVEMedAI 8/10

Investors’ Stock Portfolio: Top 10 Penny Stocks To Buy

The article says US small-cap and penny stocks are benefiting from AI-driven risk appetite, citing the Russell 2000’s 16% YTD outperformance. It lists “Top 10” penny stocks under $5, using S&P 500 10% YTD outperformance, >20% upside, and hedge-fund holdings. For HIVE (share $4.54), it reports FY2026 revenue $297.8M (+158%) and adjusted EBITDA $72.9M. For indie Semiconductor (share $4.93), Benchmark reiterates Buy and an $8 target after a €40M acquisition of ams OSRAM’s CMOS image sensor business